Lynn M. Neilson - Concepedia

Author

Lynn M. Neilson

Sidney Kimmel Cancer Center ORCID

Also Known As

L M Neilson, L. M. Neilson, L. NEILSON, L. Neilson, Lynn M Neilson, Lynn M. Neilson, Lynn Moretti Neilson, Lynn Neilson

Publications

496

Citations

H-Index

Concepts

All Affiliations

Sidney Kimmel Cancer Center Thomas Jefferson University UPMC Center for High Value Health Care Georgetown University Medical Center Georgetown University

About

Lynn M. Neilson is an author at Sidney Kimmel Cancer Center specializing in medicine, tumor biology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	346
2	Cell Biology	5	5	290
3	Health Sciences	1	1	11
4	Biostatistics	1	1	45
5	Endocrinology	1	1	64

Lynn M. Neilson

Publications

424

Citations

H-Index

Page 1

	Year	Citations
Prolactin Inhibits BCL6 Expression in Breast Cancer through a Stat5a-Dependent Mechanism Thai H. Tran, Fransiscus E. Utama, Justin Lin, Cancer Research Breast OncologyImmunologyCancer BiologyTumor BiologyTranscriptional Regulation	2010	79
Coactivation of Janus Tyrosine Kinase (Jak)1 Positively Modulates Prolactin-Jak2 Signaling in Breast Cancer: Recruitment of ERK and Signal Transducer and Activator of Transcription (Stat)3 and Enhancement of Akt and Stat5a/b Pathways Lynn M. Neilson, Jianquong Zhu, Jianwu Xie, Molecular Endocrinology Janus Tyrosine KinaseCancer BiologyTumor BiologySignaling PathwayCell Regulation	2007	64
Human prolactin receptors are insensitive to mouse prolactin: implications for xenotransplant modeling of human breast cancer in mice Fransiscus E. Utama, Matthew J. LeBaron, Lynn M. Neilson, Journal of Endocrinology Breast OncologyImmunologyHuman Breast CancerXenotransplant ModelingProlactin Receptors	2006	64
Ultrahigh density microarrays of solid samples Matthew J. LeBaron, Heidi R Crismon, Fransiscus E. Utama, Nature Methods MicroscopyBiostatisticsMedicineGene Expression ProfilingUltrahigh Density Microarrays	2005	45
Signal transducer and activator of transcription-3 and breast cancer prognosis. Takahiro Sato, Lynn M. Neilson, Amy R. Peck, PubMed Breast OncologyPathologyCancer BiologyTumor BiologyTranscriptional Regulation	2011	42
Prolactin suppresses a progestin-induced CK5-positive cell population in luminal breast cancer through inhibition of progestin-driven BCL6 expression Takami Sato, T. H. Tran, Amy R. Peck, Oncogene Progestin-driven Bcl6 ExpressionBreast OncologyImmune Checkpoint InhibitorLuminal Breast CancerBreast Cancer	2013	41
Global profiling of prolactin-modulated transcripts in breast cancer in vivo Takahiro Sato, Thai H. Tran, Amy R. Peck, Molecular Cancer	2013	30
Changes in Type 2 Diabetes Medication Utilization and Costs in the United States, 2014–2019 Lynn M. Neilson, Kiraat D. Munshi, Samuel K. Peasah, Medical Care	2021	16
Health care utilization and costs associated with switching from DPP-4i to GLP-1RA or SGLT2i: an observational cohort study Terri V. Newman, Kiraat D. Munshi, Lynn M. Neilson, Journal of Managed Care & Specialty Pharmacy	2021	12
Impact of Marijuana Legalization on Opioid Utilization in Patients Diagnosed with Pain Lynn M. Neilson, Caroline Swift, Elizabeth C.S. Swart, Journal of General Internal Medicine Opioid EpidemicPain TherapySubstance UsePain MedicineOpioid Utilization	2021	11

Page 1